Related Experiment Video
Updated: Aug 15, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inter-individual variation of inflammatory markers of cardiovascular risks and diseases
Hind Berrahmoune1, John Lamont, Peter Fitzgerald
1INSERM U525 Equipe 4, Faculté de Pharmacie, Université Henri Poincaré Nancy I, Nancy, France.
Insights
Investigating inflammation
Area of Science:
- Cardiovascular health and inflammation research.
Background:
- Cardiovascular diseases (CVDs) pose a significant public health challenge due to their complex, multifactorial origins.
- Understanding CVDs is complicated by their clinical and biological heterogeneity.
- Examining individual biological systems and their interactions offers a path to comprehending disease development.
Purpose of the Study:
- To review environmental, genetic, and epigenetic factors influencing inflammation's intermediate phenotypes (protein and RNA levels).
- To explore a novel approach using intermediate phenotype variation for elucidating complex diseases like CVDs.
- To identify potential risk markers for predicting and managing cardiovascular disease.
Main Methods:
- Literature review focusing on determinants of inflammation's intermediate phenotypes.
- Analysis of studies investigating environmental, genetic, and epigenetic factors in healthy populations.
- Synthesis of findings on protein and RNA levels as intermediate phenotypes of inflammation.
Main Results:
- Inflammation is a key factor in the onset and progression of cardiovascular diseases.
- Environmental, genetic, and epigenetic factors significantly influence intermediate inflammation phenotypes.
- Studies in healthy populations reveal insights into the regulation of these phenotypes.
Conclusions:
- Studying intermediate phenotypes of inflammation provides a promising approach to understanding cardiovascular diseases.
- Identifying determinants of these phenotypes can lead to novel risk markers.
- This approach may enable personalized treatment strategies for cardiovascular disease patients.
Abstract:
Cardiovascular diseases are a real public health problem and have multifactorial origin. Full comprehension of these diseases is very difficult because of their clinical and biological heterogeneity. The best way to understand the development of these diseases is to first investigate each biological system involved in the diseases and secondly, interactions between them. Studying intermediate phenotype variation for these biological systems is a new and promising approach for their elucidation. Among these metabolic systems, inflammation is known to be implicated in the occurrence and worsening of cardiovascular diseases. For this review, we chose to report the most important results concerning environmental, genetic and epigenetic determinants that influence intermediate phenotypes (protein and RNA levels) of inflammation. Indeed, numerous studies have investigated these determinants in healthy populations, in other words, without the influence of either disease or medication. This new approach will help to better understand the regulation of these intermediate phenotypes and to identify a panel of risk markers, which may be useful in predicting and warning those at risk and in giving adequate treatment to each patient.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...